spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  fibrotic disease 

 HSMN NewsFeed - 10 Jan 2025
Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jul 2024
Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Mar 2023
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2021
Sirnaomics Secures $105 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jun 2021
MorphImmune, Inc. Appoints Ronald Martell as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2020
Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2019
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Feb 2019
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2018
IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jul 2018
Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2017
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Dec 2017
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2017
Foresee Pharmaceuticals and TRPharm Announce License and Distribution Agreement
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 31 Jul 2017
Foresee Pharmaceuticals Announces CEO Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2017
Foresee Pharmaceuticals Announces Key Executive Appointments
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Apr 2017
Foresee Pharmaceuticals Announces Completion of USD16M Fundraising
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jan 2017
Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Nov 2016
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Oct 2016
Corbus Pharmaceuticals Receives Orphan Designation for Resunab for the Treatment of Cystic Fibrosis in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
Adheron Therapeutics to be acquired by Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 4 Jun 2014
Complexa, Inc. Completes $13 Million Series B Financing to Further Advance Clinical Development of CXA-10
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2013
Auspex Appoints Pratik Shah as CEO and Expands Executive Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Jan 2013
Galectin Therapeutics Appoints Industry Veteran Rex Horton as Executive Director of Regulatory Affairs and Quality Assurance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2012
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 15 Oct 2012
Promedior Appoints Elizabeth Trehu, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2012
Versant Ventures -- Leading Seed/Early Stage Healthcare Venture Capital Firm -- Appoints Dr. Guido Magni as Venture Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2011
Conatus Pharmaceuticals Appoints Dr. Gary Burgess as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2011
Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2010
Gilead Sciences to Acquire Arresto Biosciences for $225 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Oct 2008
Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations.
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Oct 2008
Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Surface Logix Announces Executive Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Apr 2008
CoNCERT Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2008
Pipex Pharmaceuticals Announces Cost Reduction Measures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Nov 2007
Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Oct 2007
Pipex Pharmaceuticals Appoints David A. Newsome, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jul 2007
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 3 Jul 2007
Serentis Raises £10.3 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 May 2007
Conatus Pharmaceuticals Elects Harold E. Van Wart, Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2007
Pipex Pharmaceuticals, Inc. Announces the Appointment of Daniel J. Dorman and James S. Kuo, M.D., M.B.A. to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2007
Promedior Adds to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2007
Pipex Pharmaceuticals Acquires Minority Interest in Its Effective Pharmaceuticals Subsidiary
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2006
Pipex Pharmaceuticals, Inc. Completes Corporate Name Change and New Ticker Symbol
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Pipex Therapeutics Merges With Sheffield Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2006
Resverlogix Corp. Announces License Agreement with Medtronic
Devices Interventional Cardiology Licensing
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
fibrotic disease
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.